Moderna skyrockets 29% after its early trial for a coronavirus vaccine produced antibodies in all 45 patients (MRNA) | ||
Monday, 18 May 2020 ()
 **· *Moderna announced on Monday that its early trial for its coronavirus vaccine produced antibodies in all patients. * · *Shares of the company surged 29% on Monday. * · *The company is aiming to have the vaccine ready for emergency use in the fall.* · *Watch Moderna trade live on Markets Insider.* · *Read more... |
| 0 shares | |
Credit: Veuer - Published
Company Testing Coronavirus Vaccine Reports “Positive” Early Results from a Phase 1 Trial 00:48Early data from testing on a potential coronavirus vaccine is showing a step in the right direction, according to the biotech company Moderna. |